Global Biologic Therapeutics Market Size, Status and Forecast 2021-2027

Publisher Name :
Date: 13-Jul-2021
No. of pages: 96
Inquire Before Buying

Biologic therapeutics drugs are genetically engineered proteins derived from human genetic material. They contain sugars, proteins, nucleic acids, or complex combinations of these substances, or may be living entities such as cells and tissues. In addition, biologics drugs are derived from natural sources such as animals, humans, and microorganisms that are further utilized to make therapeutic products such as vaccines, blood components, and recombinant therapeutic proteins.

First and foremost, increasing reimbursement for biologics is predicted to positively influence the biologic therapeutics market in the upcoming years. Medical insurance companies and state-run insurance schemes are increasingly accepting claims against biologic therapeutics. Biologic therapeutics are gaining popularity due the efficacy of biologic therapeutic drugs and fewer side effects than chemical-based drugs. This is because biologic drugs are obtained from natural sources such as plants, or even living components such as cells and tissues of animals, microorganisms, or humans. These fragments are further treated to make therapeutic products such as blood components, vaccines, and recombinant therapeutic proteins.

Market Analysis and Insights: Global Biologic Therapeutics Market

The global Biologic Therapeutics market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Biologic Therapeutics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Biologic Therapeutics market in terms of revenue.

On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Biologic Therapeutics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Biologic Therapeutics market.

Global Biologic Therapeutics Scope and Market Size

Biologic Therapeutics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Biologic Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type

- Vaccines

- Blood Products

- Allergenic Extracts

- Human Cells and Tissues

- Gene Therapies

- Protein

- Cellular Therapies

- Xenotransplantation Products

Segment by Application

- Rheumatoid Arthritis

- Anemia

- Cancer

- Diabetes

- Others

By Region

- North America

- - U.S.

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- - Nordic

- - Rest of Europe

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - Southeast Asia

- - India

- - Australia

- - Rest of Asia

- Latin America

- - Mexico

- - Brazil

- - Rest of Latin America

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

- - Rest of MEA

By Company

- Pfizer

- Novartis Global

- AstraZeneca

- Merck

- GlaxoSmithKline

- Aurobindo Pharma

Global Biologic Therapeutics Market Size, Status and Forecast 2021-2027

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Biologic Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Vaccines
1.2.3 Blood Products
1.2.4 Allergenic Extracts
1.2.5 Human Cells and Tissues
1.2.6 Gene Therapies
1.2.7 Protein
1.2.8 Cellular Therapies
1.2.9 Xenotransplantation Products
1.3 Market by Application
1.3.1 Global Biologic Therapeutics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Rheumatoid Arthritis
1.3.3 Anemia
1.3.4 Cancer
1.3.5 Diabetes
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Biologic Therapeutics Market Perspective (2016-2027)
2.2 Biologic Therapeutics Growth Trends by Regions
2.2.1 Biologic Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Biologic Therapeutics Historic Market Share by Regions (2016-2021)
2.2.3 Biologic Therapeutics Forecasted Market Size by Regions (2022-2027)
2.3 Biologic Therapeutics Industry Dynamic
2.3.1 Biologic Therapeutics Market Trends
2.3.2 Biologic Therapeutics Market Drivers
2.3.3 Biologic Therapeutics Market Challenges
2.3.4 Biologic Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Biologic Therapeutics Players by Revenue
3.1.1 Global Top Biologic Therapeutics Players by Revenue (2016-2021)
3.1.2 Global Biologic Therapeutics Revenue Market Share by Players (2016-2021)
3.2 Global Biologic Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Biologic Therapeutics Revenue
3.4 Global Biologic Therapeutics Market Concentration Ratio
3.4.1 Global Biologic Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Biologic Therapeutics Revenue in 2020
3.5 Biologic Therapeutics Key Players Head office and Area Served
3.6 Key Players Biologic Therapeutics Product Solution and Service
3.7 Date of Enter into Biologic Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Biologic Therapeutics Breakdown Data by Type
4.1 Global Biologic Therapeutics Historic Market Size by Type (2016-2021)
4.2 Global Biologic Therapeutics Forecasted Market Size by Type (2022-2027)
5 Biologic Therapeutics Breakdown Data by Application
5.1 Global Biologic Therapeutics Historic Market Size by Application (2016-2021)
5.2 Global Biologic Therapeutics Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Biologic Therapeutics Market Size (2016-2027)
6.2 North America Biologic Therapeutics Market Size by Type
6.2.1 North America Biologic Therapeutics Market Size by Type (2016-2021)
6.2.2 North America Biologic Therapeutics Market Size by Type (2022-2027)
6.2.3 North America Biologic Therapeutics Market Size by Type (2016-2027)
6.3 North America Biologic Therapeutics Market Size by Application
6.3.1 North America Biologic Therapeutics Market Size by Application (2016-2021)
6.3.2 North America Biologic Therapeutics Market Size by Application (2022-2027)
6.3.3 North America Biologic Therapeutics Market Size by Application (2016-2027)
6.4 North America Biologic Therapeutics Market Size by Country
6.4.1 North America Biologic Therapeutics Market Size by Country (2016-2021)
6.4.2 North America Biologic Therapeutics Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Biologic Therapeutics Market Size (2016-2027)
7.2 Europe Biologic Therapeutics Market Size by Type
7.2.1 Europe Biologic Therapeutics Market Size by Type (2016-2021)
7.2.2 Europe Biologic Therapeutics Market Size by Type (2022-2027)
7.2.3 Europe Biologic Therapeutics Market Size by Type (2016-2027)
7.3 Europe Biologic Therapeutics Market Size by Application
7.3.1 Europe Biologic Therapeutics Market Size by Application (2016-2021)
7.3.2 Europe Biologic Therapeutics Market Size by Application (2022-2027)
7.3.3 Europe Biologic Therapeutics Market Size by Application (2016-2027)
7.4 Europe Biologic Therapeutics Market Size by Country
7.4.1 Europe Biologic Therapeutics Market Size by Country (2016-2021)
7.4.2 Europe Biologic Therapeutics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Biologic Therapeutics Market Size (2016-2027)
8.2 Asia-Pacific Biologic Therapeutics Market Size by Type
8.2.1 Asia-Pacific Biologic Therapeutics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Biologic Therapeutics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Biologic Therapeutics Market Size by Type (2016-2027)
8.3 Asia-Pacific Biologic Therapeutics Market Size by Application
8.3.1 Asia-Pacific Biologic Therapeutics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Biologic Therapeutics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Biologic Therapeutics Market Size by Application (2016-2027)
8.4 Asia-Pacific Biologic Therapeutics Market Size by Region
8.4.1 Asia-Pacific Biologic Therapeutics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Biologic Therapeutics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Biologic Therapeutics Market Size (2016-2027)
9.2 Latin America Biologic Therapeutics Market Size by Type
9.2.1 Latin America Biologic Therapeutics Market Size by Type (2016-2021)
9.2.2 Latin America Biologic Therapeutics Market Size by Type (2022-2027)
9.2.3 Latin America Biologic Therapeutics Market Size by Type (2016-2027)
9.3 Latin America Biologic Therapeutics Market Size by Application
9.3.1 Latin America Biologic Therapeutics Market Size by Application (2016-2021)
9.3.2 Latin America Biologic Therapeutics Market Size by Application (2022-2027)
9.3.3 Latin America Biologic Therapeutics Market Size by Application (2016-2027)
9.4 Latin America Biologic Therapeutics Market Size by Country
9.4.1 Latin America Biologic Therapeutics Market Size by Country (2016-2021)
9.4.2 Latin America Biologic Therapeutics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Biologic Therapeutics Market Size (2016-2027)
10.2 Middle East & Africa Biologic Therapeutics Market Size by Type
10.2.1 Middle East & Africa Biologic Therapeutics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Biologic Therapeutics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Biologic Therapeutics Market Size by Type (2016-2027)
10.3 Middle East & Africa Biologic Therapeutics Market Size by Application
10.3.1 Middle East & Africa Biologic Therapeutics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Biologic Therapeutics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Biologic Therapeutics Market Size by Application (2016-2027)
10.4 Middle East & Africa Biologic Therapeutics Market Size by Country
10.4.1 Middle East & Africa Biologic Therapeutics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Biologic Therapeutics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Biologic Therapeutics Introduction
11.1.4 Pfizer Revenue in Biologic Therapeutics Business (2016-2021)
11.1.5 Pfizer Recent Development
11.2 Novartis Global
11.2.1 Novartis Global Company Details
11.2.2 Novartis Global Business Overview
11.2.3 Novartis Global Biologic Therapeutics Introduction
11.2.4 Novartis Global Revenue in Biologic Therapeutics Business (2016-2021)
11.2.5 Novartis Global Recent Development
11.3 AstraZeneca
11.3.1 AstraZeneca Company Details
11.3.2 AstraZeneca Business Overview
11.3.3 AstraZeneca Biologic Therapeutics Introduction
11.3.4 AstraZeneca Revenue in Biologic Therapeutics Business (2016-2021)
11.3.5 AstraZeneca Recent Development
11.4 Merck
11.4.1 Merck Company Details
11.4.2 Merck Business Overview
11.4.3 Merck Biologic Therapeutics Introduction
11.4.4 Merck Revenue in Biologic Therapeutics Business (2016-2021)
11.4.5 Merck Recent Development
11.5 GlaxoSmithKline
11.5.1 GlaxoSmithKline Company Details
11.5.2 GlaxoSmithKline Business Overview
11.5.3 GlaxoSmithKline Biologic Therapeutics Introduction
11.5.4 GlaxoSmithKline Revenue in Biologic Therapeutics Business (2016-2021)
11.5.5 GlaxoSmithKline Recent Development
11.6 Aurobindo Pharma
11.6.1 Aurobindo Pharma Company Details
11.6.2 Aurobindo Pharma Business Overview
11.6.3 Aurobindo Pharma Biologic Therapeutics Introduction
11.6.4 Aurobindo Pharma Revenue in Biologic Therapeutics Business (2016-2021)
11.6.5 Aurobindo Pharma Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Biologic Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Vaccines
Table 3. Key Players of Blood Products
Table 4. Key Players of Allergenic Extracts
Table 5. Key Players of Human Cells and Tissues
Table 6. Key Players of Gene Therapies
Table 7. Key Players of Protein
Table 8. Key Players of Cellular Therapies
Table 9. Key Players of Xenotransplantation Products
Table 10. Global Biologic Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 11. Global Biologic Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 12. Global Biologic Therapeutics Market Size by Regions (2016-2021) & (US$ Million)
Table 13. Global Biologic Therapeutics Market Share by Regions (2016-2021)
Table 14. Global Biologic Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 15. Global Biologic Therapeutics Market Share by Regions (2022-2027)
Table 16. Biologic Therapeutics Market Trends
Table 17. Biologic Therapeutics Market Drivers
Table 18. Biologic Therapeutics Market Challenges
Table 19. Biologic Therapeutics Market Restraints
Table 20. Global Biologic Therapeutics Revenue by Players (2016-2021) & (US$ Million)
Table 21. Global Biologic Therapeutics Market Share by Players (2016-2021)
Table 22. Global Top Biologic Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Biologic Therapeutics as of 2020)
Table 23. Ranking of Global Top Biologic Therapeutics Companies by Revenue (US$ Million) in 2020
Table 24. Global 5 Largest Players Market Share by Biologic Therapeutics Revenue (CR5 and HHI) & (2016-2021)
Table 25. Key Players Headquarters and Area Served
Table 26. Key Players Biologic Therapeutics Product Solution and Service
Table 27. Date of Enter into Biologic Therapeutics Market
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Biologic Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 30. Global Biologic Therapeutics Revenue Market Share by Type (2016-2021)
Table 31. Global Biologic Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 32. Global Biologic Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 33. Global Biologic Therapeutics Market Size Share by Application (2016-2021) & (US$ Million)
Table 34. Global Biologic Therapeutics Revenue Market Share by Application (2016-2021)
Table 35. Global Biologic Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 36. Global Biologic Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 37. North America Biologic Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 38. North America Biologic Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 39. North America Biologic Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 40. North America Biologic Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 41. North America Biologic Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 42. North America Biologic Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 43. Europe Biologic Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 44. Europe Biologic Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 45. Europe Biologic Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 46. Europe Biologic Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 47. Europe Biologic Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 48. Europe Biologic Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Biologic Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 50. Asia-Pacific Biologic Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 51. Asia-Pacific Biologic Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 52. Asia-Pacific Biologic Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 53. Asia-Pacific Biologic Therapeutics Market Size by Region (2016-2021) & (US$ Million)
Table 54. Asia-Pacific Biologic Therapeutics Market Size by Region (2022-2027) & (US$ Million)
Table 55. Latin America Biologic Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 56. Latin America Biologic Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 57. Latin America Biologic Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 58. Latin America Biologic Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 59. Latin America Biologic Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 60. Latin America Biologic Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Biologic Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 62. Middle East & Africa Biologic Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 63. Middle East & Africa Biologic Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 64. Middle East & Africa Biologic Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 65. Middle East & Africa Biologic Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 66. Middle East & Africa Biologic Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 67. Pfizer Company Details
Table 68. Pfizer Business Overview
Table 69. Pfizer Biologic Therapeutics Product
Table 70. Pfizer Revenue in Biologic Therapeutics Business (2016-2021) & (US$ Million)
Table 71. Pfizer Recent Development
Table 72. Novartis Global Company Details
Table 73. Novartis Global Business Overview
Table 74. Novartis Global Biologic Therapeutics Product
Table 75. Novartis Global Revenue in Biologic Therapeutics Business (2016-2021) & (US$ Million)
Table 76. Novartis Global Recent Development
Table 77. AstraZeneca Company Details
Table 78. AstraZeneca Business Overview
Table 79. AstraZeneca Biologic Therapeutics Product
Table 80. AstraZeneca Revenue in Biologic Therapeutics Business (2016-2021) & (US$ Million)
Table 81. AstraZeneca Recent Development
Table 82. Merck Company Details
Table 83. Merck Business Overview
Table 84. Merck Biologic Therapeutics Product
Table 85. Merck Revenue in Biologic Therapeutics Business (2016-2021) & (US$ Million)
Table 86. Merck Recent Development
Table 87. GlaxoSmithKline Company Details
Table 88. GlaxoSmithKline Business Overview
Table 89. GlaxoSmithKline Biologic Therapeutics Product
Table 90. GlaxoSmithKline Revenue in Biologic Therapeutics Business (2016-2021) & (US$ Million)
Table 91. GlaxoSmithKline Recent Development
Table 92. Aurobindo Pharma Company Details
Table 93. Aurobindo Pharma Business Overview
Table 94. Aurobindo Pharma Biologic Therapeutics Product
Table 95. Aurobindo Pharma Revenue in Biologic Therapeutics Business (2016-2021) & (US$ Million)
Table 96. Aurobindo Pharma Recent Development
Table 97. Research Programs/Design for This Report
Table 98. Key Data Information from Secondary Sources
Table 99. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Biologic Therapeutics Market Share by Type: 2020 VS 2027
Figure 2. Vaccines Features
Figure 3. Blood Products Features
Figure 4. Allergenic Extracts Features
Figure 5. Human Cells and Tissues Features
Figure 6. Gene Therapies Features
Figure 7. Protein Features
Figure 8. Cellular Therapies Features
Figure 9. Xenotransplantation Products Features
Figure 10. Global Biologic Therapeutics Market Share by Application: 2020 VS 2027
Figure 11. Rheumatoid Arthritis Case Studies
Figure 12. Anemia Case Studies
Figure 13. Cancer Case Studies
Figure 14. Diabetes Case Studies
Figure 15. Others Case Studies
Figure 16. Biologic Therapeutics Report Years Considered
Figure 17. Global Biologic Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 18. Global Biologic Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 19. Global Biologic Therapeutics Market Share by Regions: 2020 VS 2027
Figure 20. Global Biologic Therapeutics Market Share by Regions (2022-2027)
Figure 21. Global Biologic Therapeutics Market Share by Players in 2020
Figure 22. Global Top Biologic Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Biologic Therapeutics as of 2020
Figure 23. The Top 10 and 5 Players Market Share by Biologic Therapeutics Revenue in 2020
Figure 24. Global Biologic Therapeutics Revenue Market Share by Type (2016-2021)
Figure 25. Global Biologic Therapeutics Revenue Market Share by Type (2022-2027)
Figure 26. North America Biologic Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. North America Biologic Therapeutics Market Share by Type (2016-2027)
Figure 28. North America Biologic Therapeutics Market Share by Application (2016-2027)
Figure 29. North America Biologic Therapeutics Market Share by Country (2016-2027)
Figure 30. United States Biologic Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Canada Biologic Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Europe Biologic Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Europe Biologic Therapeutics Market Share by Type (2016-2027)
Figure 34. Europe Biologic Therapeutics Market Share by Application (2016-2027)
Figure 35. Europe Biologic Therapeutics Market Share by Country (2016-2027)
Figure 36. Germany Biologic Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. France Biologic Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. U.K. Biologic Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Italy Biologic Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Russia Biologic Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Nordic Biologic Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Asia-Pacific Biologic Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Asia-Pacific Biologic Therapeutics Market Share by Type (2016-2027)
Figure 44. Asia-Pacific Biologic Therapeutics Market Share by Application (2016-2027)
Figure 45. Asia-Pacific Biologic Therapeutics Market Share by Region (2016-2027)
Figure 46. China Biologic Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Japan Biologic Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. South Korea Biologic Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Southeast Asia Biologic Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. India Biologic Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Australia Biologic Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Latin America Biologic Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Latin America Biologic Therapeutics Market Share by Type (2016-2027)
Figure 54. Latin America Biologic Therapeutics Market Share by Application (2016-2027)
Figure 55. Latin America Biologic Therapeutics Market Share by Country (2016-2027)
Figure 56. Mexico Biologic Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Brazil Biologic Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Middle East & Africa Biologic Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Middle East & Africa Biologic Therapeutics Market Share by Type (2016-2027)
Figure 60. Middle East & Africa Biologic Therapeutics Market Share by Application (2016-2027)
Figure 61. Middle East & Africa Biologic Therapeutics Market Share by Country (2016-2027)
Figure 62. Turkey Biologic Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 63. Saudi Arabia Biologic Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 64. UAE Biologic Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 65. Pfizer Revenue Growth Rate in Biologic Therapeutics Business (2016-2021)
Figure 66. Novartis Global Revenue Growth Rate in Biologic Therapeutics Business (2016-2021)
Figure 67. AstraZeneca Revenue Growth Rate in Biologic Therapeutics Business (2016-2021)
Figure 68. Merck Revenue Growth Rate in Biologic Therapeutics Business (2016-2021)
Figure 69. GlaxoSmithKline Revenue Growth Rate in Biologic Therapeutics Business (2016-2021)
Figure 70. Aurobindo Pharma Revenue Growth Rate in Biologic Therapeutics Business (2016-2021)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed
  • Global Thyroid Gland Disorders Treatment Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 80
    Thyroid Gland Disorder Treatment is a kind of treatment method, which aims to The thyroid disorder patients, such as hypothyroidism patients and hyperthyroidism patients. When The thyroid gland does not produce sufficient hypothyroidism or too much hyperthyroidism, The body metabolism and functioning will be disrupted. The global Thyroid Gland Disorders Treatment market was valued at US$ 2950 million in 2023 and is anticipated to reach US$ 3871.9 million by 2030, witnessing a CAGR o......
  • Global Brachytherapy Afterloaders, Brachytherapy Seeds Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 98
    According to our LPI (LP Information) latest study, the global Brachytherapy Afterloaders, Brachytherapy Seeds market size was valued at US$ 150.8 million in 2023. With growing demand in downstream market, the Brachytherapy Afterloaders, Brachytherapy Seeds is forecast to a readjusted size of US$ 168.1 million by 2030 with a CAGR of 1.6% during review period. The research report highlights the growth potential of the global Brachytherapy Afterloaders, Brachytherapy Seeds market. Brachyth......
  • Global Peptide Therapeutics Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 109
    According to our LPI (LP Information) latest study, the global Peptide Therapeutics market size was valued at US$ 33800 million in 2023. With growing demand in downstream market, the Peptide Therapeutics is forecast to a readjusted size of US$ 63130 million by 2030 with a CAGR of 9.3% during review period. The research report highlights the growth potential of the global Peptide Therapeutics market. Peptide Therapeutics are expected to show stable growth in the future market. However, pr......
  • Global Microbiome Therapeutics Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 155
    According to our LPI (LP Information) latest study, the global Microbiome Therapeutics market size was valued at US$ 89 million in 2023. With growing demand in downstream market, the Microbiome Therapeutics is forecast to a readjusted size of US$ 916.3 million by 2030 with a CAGR of 39.5% during review period. The research report highlights the growth potential of the global Microbiome Therapeutics market. Microbiome Therapeutics are expected to show stable growth in the future market. H......
  • Global Anti-inflammatory Therapeutics Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 109
    According to our LPI (LP Information) latest study, the global Anti-inflammatory Therapeutics market size was valued at US$ 108140 million in 2023. With growing demand in downstream market, the Anti-inflammatory Therapeutics is forecast to a readjusted size of US$ 166150 million by 2030 with a CAGR of 6.3% during review period. The research report highlights the growth potential of the global Anti-inflammatory Therapeutics market. Anti-inflammatory Therapeutics are expected to show stabl......
  • Global Enzyme Replacement Therapy Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 113
    According to our LPI (LP Information) latest study, the global Enzyme Replacement Therapy market size was valued at US$ 11570 million in 2023. With growing demand in downstream market, the Enzyme Replacement Therapy is forecast to a readjusted size of US$ 29900 million by 2030 with a CAGR of 14.5% during review period. The research report highlights the growth potential of the global Enzyme Replacement Therapy market. Enzyme Replacement Therapy are expected to show stable growth in the f......
  • Global Infantile Spasms Therapeutics Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 84
    According to our LPI (LP Information) latest study, the global Infantile Spasms Therapeutics market size was valued at US$ 138.9 million in 2023. With growing demand in downstream market, the Infantile Spasms Therapeutics is forecast to a readjusted size of US$ 179.6 million by 2030 with a CAGR of 3.7% during review period. The research report highlights the growth potential of the global Infantile Spasms Therapeutics market. Infantile Spasms Therapeutics are expected to show stable grow......
  • Global Hormone Replacement Therapy Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 128
    According to our LPI (LP Information) latest study, the global Hormone Replacement Therapy market size was valued at US$ 16090 million in 2023. With growing demand in downstream market, the Hormone Replacement Therapy is forecast to a readjusted size of US$ 17930 million by 2030 with a CAGR of 1.6% during review period. The research report highlights the growth potential of the global Hormone Replacement Therapy market. Hormone Replacement Therapy are expected to show stable growth in th......
  • Global Plasma Therapy Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 107
    According to our LPI (LP Information) latest study, the global Plasma Therapy market size was valued at US$ 265.3 million in 2023. With growing demand in downstream market, the Plasma Therapy is forecast to a readjusted size of US$ 529.4 million by 2030 with a CAGR of 10.4% during review period. The research report highlights the growth potential of the global Plasma Therapy market. Plasma Therapy are expected to show stable growth in the future market. However, product differentiation, ......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs